In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Focus on National Prevention Strategies: Bulgaria

Dr. Evgeniy Goshev, National CVD Prevention Coordinator in Bulgaria

Bulgaria belongs to the high risk regions of Europe for CVD. According to National statistics (National Center of Public Health and Analyses, Ministry of Health) premature mortality rate (below the age of 65 years) is highest for the period 2005-2011 and equals approximately 30%.
As the decrease in deaths from CHD worldwide is mostly attributed to change of risk factors, the Bulgarian Society of Cardiology (BSC) is focussed on the creation of a broad Alliance for Prevention of CVD under the leadership of Working Group on Epidemiology, Prevention and Rehabilitation of CVD, which is part of BSC.

As said by Professor Diederick E Grobbee; we do recognize that "attention to prevention is sign of civilization” (1)


The main task is to implement The European Guidelines on CVD prevention in clinical practice version 2012 (2) at national level and formulate the national priorities. To put the theory in practice the BSC and its Working Group on Epidemiology, Prevention and Rehabilitation of CVD have developed the following initiatives:

  • Close cooperation with the National Organization of General Practice, which includes organization of joined Symposia on prevention of CVD and vocational training in the field of control and management of risk factors. The goal is the reduction of premature deaths from CVD (before 65 years of age) by 20% until 2020.
  • Development of nurses led programmes on CVD prevention. This is performed together with the National Organization of Nurses.
  • BSC and the Working Group on Epidemiology, Prevention and Rehabilitation of CVD intend to organize every year a national forum dedicated to CVD prevention, where national programs and results of national and international trials will be presented. The first symposium took place in May 2012 and we managed to attract representatives of National Sports Academy, Bulgarian Academy of Science, Chair of Medical Genetics, the Section of Hygiene of Nutrition of the Institute of Public Health.
  • Together with the National Patients Organization we started issuing booklets, which will form a library for the patients. The slogan promoted is ”the healthy heart is in your hands!”
  • We intend to give rise next year to a Working Group on Pharmaco-economics together with The Pharmaceutical Faculty and representatives of the pharmaceutical industry.
  • We still need to develop better cooperation with Food Industry and implementation of healthy diets in everyday life – such as reduction of salt and saturated fats intake.
  • BSC and the Working Group on Epidemiology, Prevention and Rehabilitation of CVD stand firmly behind the Government's decision for smoking bans as an effective measure to implement healthy way of living.
  • The World Heart Day is celebrated around the country and is used to present ourselves in the media and to promote prevention of CVD. This year during The World Heart Day we started organizing medical practices on Preventive cardiology.

For more information, please contact:

Dr. Evgeniy Goshev
National CVD Prevention Coordinator in Bulgaria
Professor Asen Goudev (email)
Past President of BSC (2010-2012)


(1) The era of preventive cardiology
Diederick Grobbee
European Journal of Preventive Cardiology February 2012 19: 3-4, doi:10.1177/2047487311434431
(2) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EHJ 2012:33;1635–1701